RhumbLine Advisers
VERA icon

RhumbLine Advisers’s Vera Therapeutics VERA Stock Holding History

RhumbLine Advisers’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Buy
79,307
+4,772
+6% +$178K ﹤0.01% 1654
2026
Q1 		$3M Buy
74,535
+8,024
+12% +$346K ﹤0.01% 1648
2025
Q4 		$3.37M Sell
66,511
-6,448
-9% -$229K ﹤0.01% 1603
2025
Q3 		$2.12M Sell
72,959
-2,111
-3% -$48.8K ﹤0.01% 1878
2025
Q2 		$1.77M Buy
75,070
+11,881
+19% +$267K ﹤0.01% 1952
2025
Q1 		$1.52M Buy
63,189
+4,600
+8% +$148K ﹤0.01% 1956
2024
Q4 		$2.48M Buy
58,589
+6,515
+13% +$288K ﹤0.01% 1769
2024
Q3 		$2.3M Sell
52,074
-2,785
-5% -$106K ﹤0.01% 1828
2024
Q2 		$1.98M Sell
54,859
-2,888
-5% -$115K ﹤0.01% 1890
2024
Q1 		$2.49M Buy
57,747
+9,748
+20% +$347K ﹤0.01% 1791
2023
Q4 		$738K Sell
47,999
-412
-0.9% -$5.23K ﹤0.01% 2436
2023
Q3 		$664K Buy
48,411
+5,260
+12% +$90.2K ﹤0.01% 2432
2023
Q2 		$693K Buy
43,151
+15,857
+58% +$143K ﹤0.01% 2492
2023
Q1 		$212K Buy
27,294
+9,241
+51% +$71.3K ﹤0.01% 2728
2022
Q4 		$349K Buy
18,053
+453
+3% +$8.2K ﹤0.01% 2613
2022
Q3 		$375K Buy
17,600
+1,328
+8% +$24.9K ﹤0.01% 2628
2022
Q2 		$221K Buy
16,272
+5,887
+57% +$103K ﹤0.01% 2894
2022
Q1 		$244K Buy
+10,385
New +$223K ﹤0.01% 2703

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RhumbLine Advisers's VERA Position: Q2 2026 in Review

RhumbLine Advisers increased its Vera Therapeutics (VERA) stake by 6.4% in Q2 2026, buying an estimated $178K and bringing the position to 79,307 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

RhumbLine Advisers first reported a position in VERA in Q1 2022 and has held it in 18 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • RhumbLine Advisers held 79,307 shares of Vera Therapeutics worth $3.4M as of Q2 2026.
  • RhumbLine Advisers bought 4,772 Vera Therapeutics shares in Q2 2026, an estimated $178K.
  • Vera Therapeutics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1654 holding.
  • RhumbLine Advisers first reported a position in Vera Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.